Justin Stebbing, MD

Dr. Justin Stebbing is the Chairman of Zephyr AI’s Scientific and Medical Advisory Board. Justin is Editor of Nature’s cancer journal Oncogene and a Professor of Biomedical Sciences at ARU in Cambridge. He specializes in a range of solid malignancies (breast, GI, lung, others) including difficult cases with few conventional options and has published over […]

Alan Barge, MD

Dr. Alan Barge is the Chairman of Modra Pharmaceuticals, the founder of Carrick Therapeutics and the Co-Founder of ASLAN Pharmaceuticals. Alan is the former VP of Clinical and Head of Oncology and Infection, AstraZeneca Dr. Barge trained in medicine at Oxford and London and specialized in oncology and hematology. He joined Amgen in 1990, as […]

Richard L. Schilsky, MD

Dr. Richard L. Schilsky is the Former EVP and Chief Medical Officer of the American Society of Clinical Oncology (ASCO) and a Professor Emeritus at the University of Chicago. Dr. Schilsky is an international expert in gastrointestinal malignancies and cancer pharmacology, having published more than 400 scientific articles, reviews, and commentaries. He has served on […]